H Share Announcement: Monthly Report on Securities Changes

✨ AI Summary

This announcement provides the monthly report on securities changes for Kailaiying Pharmaceutical Group (Tianjin) Co., Ltd. as of May 31, 2026. The total issued share capital remains unchanged at RMB 360,874,970. The report confirms compliance with public shareholding requirements for both H shares and A shares.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

I. Changes in Statutory/Registered Capital

Share Class: Ordinary Shares
- Share Type: H
- Listed on Hong Kong Stock Exchange: Yes
- Stock Code: 06821
- Description: H shares statutory/registered shares
- Number of Statutory/Registered Shares at End of Last Month: 27,834,510
- Par Value: RMB 1
- Statutory/Registered Capital at End of Last Month: RMB 27,834,510
- Increase/Decrease: 0
- Number of Statutory/Registered Shares at End of This Month: 27,834,510
- Par Value: RMB 1
- Statutory/Registered Capital at End of This Month: RMB 27,834,510
Share Class: Ordinary Shares
- Share Type: A
- Listed on Hong Kong Stock Exchange: No
- Stock Code: 002821
- Description: A shares (Shenzhen Stock Exchange)
- Number of Statutory/Registered Shares at End of Last Month: 333,040,460
- Par Value: RMB 1
- Statutory/Registered Capital at End of Last Month: RMB 333,040,460
- Increase/Decrease: 0
- Number of Statutory/Registered Shares at End of This Month: 333,040,460
- Par Value: RMB 1
- Statutory/Registered Capital at End of This Month: RMB 333,040,460

Total Statutory/Registered Capital at End of This Month: RMB 360,874,970

Note:
Since Kailaiying Pharmaceutical Group (Tianjin) Co., Ltd. is registered in the People's Republic of China, the concept of "statutory capital" does not apply. The information in the first part refers to "issued capital."

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.